We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
Roche’s companion diagnostic for endometrial cancer detection gets FDA nod
The companion diagnostic (CDx) uses a comprehensive panel of DNA MMR biomarkers tested by immunohistochemistry (IHC). (Credit: F. Hoffmann-La Roche Ltd)